Strata Critical Medical Inc. logo

Strata Critical Medical Inc.

SRTA | NASDAQ
Chart Builder DCF Calculator
$5.40
+$0.06 (+1.12%)
At close: Sep 21, 2026, 4:00 PM ET
$5.31
-$0.09 (-1.67%)
Pre-market: Sep 22, 2026, 4:56 AM ET

Market Data

Market Cap
$462.05M
Enterprise Value
$448.75M
Beta
2.26
Average Volume
1.1M
Shares Outstanding (Diluted)
86.21M
Shares Change YoY
6.05%
Institutional Ownership
N/A
Exchange
NASDAQ
ISIN
US0926671043

Price Performance

Price Change 1M
-13.5%
Price Change 3M
-3.0%
Price Change 6M
23.3%
Price Change YTD
9.5%
Price Change 1Y
-8.0%
Price Change 3Y
102.3%
Price Change 5Y
-53.6%
1M CAGR (ann.)
-4.5%
1Y CAGR (ann.)
2.7%
5Y CAGR (ann.)
-11.5%
All-Time CAGR
-8.4%

Valuation

PE Ratio
-22.50
Forward PE
44.00
PEG Ratio
0.03
Forward PEG
-0.10
PS Ratio
1.83
Forward PS
1.40
PB Ratio
1.67
P/FCF Ratio
-10.31
P/Adj. FCF Ratio
-7.71
P/OCF Ratio
-15.00
EV/Sales
1.75
EV/EBIT
-17.50
EV/EBITDA
-47.96
EV/FCF
-9.91
Earnings Yield
-4.4%
FCF Yield
-9.7%
Adj. FCF Yield
-13.0%

Financial Health

Net Cash
$22.75M
Total Debt
$4.26M
Cash & Short-Term Investments
$22.75M
Total Assets
$332.7M
Current Ratio
2.64
Quick Ratio
2.64
Debt / Equity Ratio
0.02
Debt / EBITDA
-0.45
Debt / FCF
-0.09
OCF / Debt
-6.35
Interest Coverage
0.00
Altman Z-Score
5.33
Piotroski F-Score
2

Margins & Profitability

Gross Profit Margin
20.6%
Operating Profit Margin
-8.0%
EBITDA Margin
-3.7%
Net Profit Margin
15.7%
FCF Margin
-17.7%
Adj. FCF Margin
-23.7%
SBC / Revenue
4.0%
SBC Impact (per share)
-33.8%

Returns

Return on Assets
12.1%
Return on Equity
14.3%
Return on Invested Capital
-7.1%
Return on Capital Employed
-7.1%
Return on Tangible Assets
24.3%

Historical Growth (CAGR)

Revenue CAGR 3Y
10.4%
Revenue CAGR 5Y
46.0%
Revenue CAGR 10Y
N/A
EPS CAGR 3Y
54.9%
EPS CAGR 5Y
6.5%
EPS CAGR 10Y
N/A
FCF CAGR 3Y
-17.1%
FCF CAGR 5Y
0.4%
FCF CAGR 10Y
N/A

Analyst Forecasts

Analyst Rating
Buy
Analyst Count
6
EPS Growth Next 3Y
N/A
Revenue Growth Next 3Y
N/A
Earnings Date
N/A
EPS Estimate (next Q)
N/A
EPS Growth Est (next Q)
N/A
Revenue Est (next Q)
N/A
Revenue Growth Est (next Q)
N/A

Fair Value Estimates

Graham Number
N/A
Graham Upside
N/A
Lynch Fair Value
N/A
Lynch Upside
N/A
Price Target
$7.25
Price Target Upside
34.3%

Cash Flow

Operating Cash Flow
$-27.02M
Free Cash Flow
$-45.3M
Adj. Free Cash Flow
$-60.63M
FCF Per Share
-$0.51
OCF Per Share
-$0.36
OCF/S Ratio
-12.1%

Income Statement

Revenue
$255.98M
Gross Profit
$52.62M
Operating Income
$-20.41M
EBITDA
$-9.36M
Net Income
$40.22M
EPS (Diluted)
-$0.24
Revenue / Employee
$782.8K
Profit / Employee
$123K
Employees
327

© 2026 bestshares.com. All rights reserved.